BioXcel Therapeutics (BTAIQ) Other Operating Expenses (2022 - 2026)
BioXcel Therapeutics (BTAIQ) recorded Other Operating Expenses of $22,000 in Q2 2026, down 79.4% from $107,000 a year earlier and down 92.2% from the prior quarter.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) Other Operating Expenses (2022 - 2026) Analysis & Trends
On a TTM basis, BioXcel Therapeutics' Other Operating Expenses came in at $348,000 as of Jun 30, 2026, down 83.6% year-over-year; for FY2025, it was $164,000, down 96.9% from FY2024.
- Annual Other Operating Expenses has a three-year compound annual growth rate of 101.7% (FY2022 to FY2025).
- Across earlier years, Other Operating Expenses came in at $5.27 million in FY2024 (-86.1%), $37.9 million in FY2023 and $20,000 in FY2022.
- Quarterly Other Operating Expenses has ranged from $9,000 in Q4 2022 to $1.17 million in Q3 2024 over the past five years.
- On a year-over-year basis, Other Operating Expenses rose in three of the last seven quarters, with an average decline of 20.0%.
- Peak year-over-year performance for Other Operating Expenses in the last five years was growth of 788.9% in Q1 2024, against a decline of 99.1% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $283,000 (Q1 2026), $32,000 (Q4 2025) and $11,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | BioXcel Therapeutics | 1.57 Mn | 1.57 Mn | 160,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22,000.00 |
| Mar 31, 2026 | 283,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 107,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 831,000.00 |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 80,000.00 |
| Dec 31, 2023 | 714,000.00 |
| Sep 30, 2023 | 512,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | 11,000.00 |
API Access
BioXcel Therapeutics Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();